Scarica l'app Stockscreener
36.13
11.03%
-4.48
Dopo l'orario di chiusura:
36.06
-0.07
-0.19%
Precedente Chiudi:
$40.61
Aprire:
$35
Volume 24 ore:
3.13M
Relative Volume:
4.28
Capitalizzazione di mercato:
$2.10B
Reddito:
$32.87M
Utile/perdita netta:
$674.31M
Rapporto P/E:
3.1805
EPS:
11.36
Flusso di cassa netto:
$-330.11M
1 W Prestazione:
-5.37%
1M Prestazione:
-0.08%
6M Prestazione:
+8.21%
1 anno Prestazione:
-19.26%
Intervallo 1D:
$32.70
$36.35
Intervallo di 1 settimana:
$32.70
$41.10
Portata 52W:
$23.41
$62.58
Agios Pharmaceuticals Inc Stock (AGIO) Company Profile
Nome
Agios Pharmaceuticals Inc
Settore
Industria
Telefono
617-649-8600
Indirizzo
88 SIDNEY STREET, CAMBRIDGE, MA
Confronta AGIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AGIO
Agios Pharmaceuticals Inc
|
36.13 | 2.28B | 32.87M | 674.31M | -330.11M | 11.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-24 | Iniziato | H.C. Wainwright | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-09-27 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-02-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-02-03 | Iniziato | Piper Sandler | Overweight |
| 2022-11-17 | Aggiornamento | Goldman | Sell → Neutral |
| 2022-07-27 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-03 | Iniziato | BofA Securities | Buy |
| 2021-07-30 | Downgrade | Goldman | Neutral → Sell |
| 2021-07-01 | Iniziato | Raymond James | Mkt Perform |
| 2021-06-10 | Iniziato | H.C. Wainwright | Buy |
| 2021-03-01 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-03-01 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-02-26 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-10-22 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-03-04 | Iniziato | Barclays | Equal Weight |
| 2019-11-26 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-09-23 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-05-23 | Ripresa | Goldman | Neutral |
| 2019-02-15 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2018-09-25 | Iniziato | Leerink Partners | Mkt Perform |
| 2018-05-23 | Iniziato | Citigroup | Buy |
| 2018-04-11 | Reiterato | Credit Suisse | Outperform |
| 2018-02-15 | Reiterato | Needham | Buy |
| 2018-02-15 | Reiterato | SunTrust | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-08-10 | Reiterato | Needham | Buy |
| 2017-08-08 | Reiterato | SunTrust | Buy |
| 2017-08-02 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2017-06-26 | Downgrade | Janney | Buy → Neutral |
| 2017-01-17 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2016-10-24 | Iniziato | Needham | Buy |
| 2016-06-13 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2016-05-18 | Reiterato | SunTrust | Buy |
Mostra tutto
Agios Pharmaceuticals Inc Borsa (AGIO) Ultime notizie
How to forecast Agios Pharmaceuticals Inc. trends using time seriesM&A Rumor & Fast Entry Momentum Alerts - Newser
Is Agios Pharmaceuticals Inc. undervalued by DCF analysisMarket Sentiment Review & Reliable Momentum Entry Alerts - khodrobank.com
Full technical analysis of Agios Pharmaceuticals Inc. stockBond Market & AI Powered Market Trend Analysis - Newser
Should you wait for a breakout in Agios Pharmaceuticals Inc.2025 Retail Activity & Fast Exit Strategy with Risk Control - Newser
Price action breakdown for Agios Pharmaceuticals Inc.Portfolio Value Summary & High Yield Stock Recommendations - Newser
Agios Pharmaceuticals Inc.’s volatility index tracking explained2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - Newser
Long term hold vs stop loss in Agios Pharmaceuticals Inc.Treasury Yields & Daily Chart Pattern Signal Reports - Newser
What MACD signals say about Agios Pharmaceuticals Inc.Weekly Stock Recap & Technical Buy Zone Confirmations - Newser
Developing predictive dashboards with Agios Pharmaceuticals Inc. dataIndex Update & Fast Momentum Entry Tips - Newser
Historical volatility pattern of Agios Pharmaceuticals Inc. visualizedEarnings Growth Summary & Daily Technical Forecast Reports - Newser
Chart Patterns Forming a Bullish Setup in Agios Pharmaceuticals Inc.Sell Signal & Free High Return Stock Watch Alerts - beatles.ru
Can trapped investors hope for a rebound in Agios Pharmaceuticals Inc.Trade Volume Report & Weekly Stock Breakout Alerts - Newser
How to track smart money flows in Agios Pharmaceuticals Inc.July 2025 Snapshot & Capital Efficient Trading Techniques - Newser
Is Agios Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Outlook & Technical Pattern Based Buy Signals - Newser
Can Agios Pharmaceuticals Inc. deliver consistent EPS growthWeekly Stock Recap & Weekly High Return Stock Opportunities - khodrobank.com
Is Agios Pharmaceuticals Inc. a turnaround storyJuly 2025 Summary & High Accuracy Investment Entry Signals - khodrobank.com
Commit To Buy Agios Pharmaceuticals At $30, Earn 34.9% Annualized Using Options - Nasdaq
Detecting support and resistance levels for Agios Pharmaceuticals Inc.Dollar Strength & Fast Moving Stock Trade Plans - Newser
Using AI based signals to follow Agios Pharmaceuticals Inc.Quarterly Trade Review & High Accuracy Trade Alerts - Newser
Is Agios Pharmaceuticals Inc. trending in predictive chart modelsLong Setup & Reliable Breakout Stock Forecasts - Newser
What moving averages say about Agios Pharmaceuticals Inc.Watch List & Safe Capital Investment Plans - Newser
Long term hold vs stop loss in Agios Pharmaceuticals Inc2025 Biggest Moves & Daily Stock Trend Watchlist - Newser
Will Agios Pharmaceuticals Inc. benefit from sector rotation2025 Buyback Activity & AI Powered Market Entry Ideas - khodrobank.com
Earnings Beat: Does Agios Pharmaceuticals Inc. outperform in volatile marketsCPI Data & Daily Risk Controlled Trade Plans - khodrobank.com
Combining machine learning predictions for Agios Pharmaceuticals Inc.2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - Newser
Will Agios Pharmaceuticals Inc. outperform tech stocksTrade Risk Summary & Community Driven Trade Alerts - khodrobank.com
Does Agios Pharmaceuticals Inc. stock reflect fundamentalsWeekly Loss Report & Technical Confirmation Alerts - khodrobank.com
Has Agios Pharmaceuticals Inc. found a price floorMarket Sentiment Review & Precise Buy Zone Identification - Newser
Does Agios Pharmaceuticals Inc. show high probability of rebound2025 Top Gainers & Community Verified Swing Trade Signals - Newser
Chart based exit strategy for Agios Pharmaceuticals Inc.2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - Newser
What technical models suggest about Agios Pharmaceuticals Inc.’s comeback - Newser
Is Agios Pharmaceuticals Inc. stock poised for growth2025 Performance Recap & Community Verified Watchlist Alerts - Newser
Published on: 2025-08-31 15:38:48 - Newser
Exit strategy if you’re trapped in Agios Pharmaceuticals Inc.Quarterly Profit Report & AI Optimized Trade Strategies - Newser
Price momentum metrics for Agios Pharmaceuticals Inc. explainedWeekly Loss Report & Technical Analysis for Trade Confirmation - Newser
Can trapped investors hope for a rebound in Agios Pharmaceuticals IncWeekly Stock Summary & Technical Buy Zone Confirmations - Newser
Agios Pharmaceuticals Inc Azioni (AGIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Agios Pharmaceuticals Inc Azioni (AGIO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Scadden David | Director |
Aug 27 '25 |
Sale |
40.00 |
200 |
8,000 |
17,603 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):